ELTP · Elite Pharmaceuticals Inc · Investor Relations
$0.25
0.00 (-0.12%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 13, 2026
The latest filing no longer states the doubt (first flagged Jun 29, 2026).
View the 10-Q filed Aug 13, 2026Market Cap
$269.28M
Shares
1.08B
Volume · Oct 21
223.38K
Avg daily vol (3M)
771.66K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-14 | Q1 FY2027 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-06-30 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-03-31 | Audio Replay - Year-End Fiscal Year 2026 Ended March 31, 2026 Conference Call | Earnings call |
| 2026-02-18 | Q3 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2025-12-31 | Audio Replay: Third Quarter Fiscal Year 2026 Ended December 31, 2025 Conference Call | Earnings call |
| 2025-06-30 | Audio Replay: Second Quarter Fiscal Year 2026 Ended June 30, 2025 Conference Call | Earnings call |
Source: http://elite.irpass.com/